Immunological efficacy of glypican-3 peptide vaccine in patients with advanced hepatocellular carcinoma

Por Tsuchiya, Nobuhiro, Yoshikawa, Toshiaki, Fujinami, Norihiro, Saito, Keigo, Mizuno, Shoichi, Sawada, Yu, Endo, Itaru, Nakatsura, Tetsuya
Publicado no Oncoimmunology (2017)

Enhancement of antitumor effect by peptide vaccine therapy in combination with anti-CD4 antibody: Study in a murine model

Por Fujinami, Norihiro, Yoshikawa, Toshiaki, Sawada, Yu, Shimomura, Manami, Iwama, Tatsuaki, Sugai, Shiori, Kitano, Shigehisa, Uemura, Yasushi, Nakatsura, Tetsuya
Publicado no Biochem Biophys Rep (2016)

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate

Por SUGAI, SHIORI, YOSHIKAWA, TOSHIAKI, IWAMA, TATSUAKI, TSUCHIYA, NOBUHIRO, UEDA, NORIHIRO, FUJINAMI, NORIHIRO, SHIMOMURA, MANAMI, ZHANG, RONG, KANEKO, SHIN, UEMURA, YASUSHI, NAKATSURA, TETSUYA
Publicado no Int J Oncol (2016)

Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors

Por Tsuchiya, Nobuhiro, Hosono, Ako, Yoshikawa, Toshiaki, Shoda, Kayoko, Nosaka, Kazuto, Shimomura, Manami, Hara, Junichi, Nitani, Chika, Manabe, Atsushi, Yoshihara, Hiroki, Hosoya, Yosuke, Kaneda, Hide, Kinoshita, Yoshiaki, Kohashi, Kenichi, Yoshimura, Kenichi, Fujinami, Norihiro, Saito, Keigo, Mizuno, Shoichi, Nakatsura, Tetsuya
Publicado no Oncoimmunology (2017)